Key result
Recurrent unexplained resting sinus tachycardia is linked to a ~12-fold higher risk of adverse cardiovascular outcomes.
Why the study?
Whether unexplained resting sinus tachycardia is associated with adverse cardiovascular outcomes and mortality in oncology populations remains poorly defined.
Does recurrent unexplained resting sinus tachycardia predict adverse cardiovascular outcomes in adult cancer patients?
Cohort (n=198)
No
Does recurrent unexplained resting sinus tachycardia predict adverse cardiovascular outcomes in adult cancer patients?
Recurrent unexplained resting sinus tachycardia in cancer patients is a strong, independent predictor of adverse cardiovascular outcomes and MACE, serving as an accessible marker of cardiovascular vulnerability.
Answers are grounded in this paper and cite their sources.
May flag higher CV risk in cancer patients; hypothesis-generating, requiring prospective validation before practice change.
Background: Recurrent unexplained resting sinus tachycardia is common in cancer patients and is frequently attributed to reversible physiologic stressors. Whether unexplained resting sinus tachycardia is associated with adverse cardiovascular outcomes (ACVO) and mortality in oncology populations remains poorly defined. Methods: = 160). The primary outcome was ACVO; secondary outcomes included major adverse cardiovascular events (MACE) and all-cause mortality. Logistic regression and Cox proportional hazards models were used for multivariable analysis. A landmark sensitivity analysis was additionally performed to address potential immortal-time bias. Conclusion: Recurrent unexplained resting sinus tachycardia identifies patients with cancer at increased risk of both MACE and ACVO, although residual confounding may have inflated the observed associations. Sinus tachycardia was not independently associated with mortality after adjustment for illness burden. Recurrent sinus tachycardia may serve as an accessible marker of cardiovascular vulnerability that warrants prospective investigation in cardio-oncology.
No takes yet. Share an insight, caveat, or question.
Sakan et al. (2026) conducted a cohort in Cancer (n=198). Recurrent unexplained resting sinus tachycardia vs. Normal sinus rhythm was evaluated on Adverse cardiovascular outcomes (ACVO) (composite of MACE and heart failure) (Adjusted OR 12.27, 95% CI 5.14-29.27, p=<0.001). Recurrent unexplained resting sinus tachycardia was associated with a increased risk of adverse cardiovascular outcomes compared to normal sinus rhythm.
Synapse has enriched 10 related papers. Consider them for comparative context: